These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 37071054)

  • 21. Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes : Lessons from the FIGARO-DKD trial.
    Haller H
    Herz; 2022 Oct; 47(5):401-409. PubMed ID: 36094559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes and the kidney.
    Chowdhury TA; Ali O
    Clin Med (Lond); 2021 Jul; 21(4):e318-e322. PubMed ID: 35192470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review.
    Morales J; Palmer BF
    Postgrad Med; 2024 Mar; 136(2):111-119. PubMed ID: 38344772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk.
    Stephens JW; Brown KE; Min T
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():32-45. PubMed ID: 32267078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
    Warren AM; Knudsen ST; Cooper ME
    Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867
    [No Abstract]   [Full Text] [Related]  

  • 26. SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review.
    Alicic RZ; Johnson EJ; Tuttle KR
    Am J Kidney Dis; 2018 Aug; 72(2):267-277. PubMed ID: 29866460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
    Khoo CM; Deerochanawong C; Chan SP; Matawaran B; Sheu WH; Chan J; Mithal A; Luk A; Suastika K; Yoon KH; Ji L; Man NH; Pollock C
    Diabetes Obes Metab; 2021 Feb; 23(2):299-317. PubMed ID: 33155749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Diabetic Kidney Disease: Current and Future.
    Yamazaki T; Mimura I; Tanaka T; Nangaku M
    Diabetes Metab J; 2021 Jan; 45(1):11-26. PubMed ID: 33508907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
    Wheeler DC; Stefansson BV; Batiushin M; Bilchenko O; Cherney DZI; Chertow GM; Douthat W; Dwyer JP; Escudero E; Pecoits-Filho R; Furuland H; Górriz JL; Greene T; Haller H; Hou FF; Kang SW; Isidto R; Khullar D; Mark PB; McMurray JJV; Kashihara N; Nowicki M; Persson F; Correa-Rotter R; Rossing P; Toto RD; Umanath K; Van Bui P; Wittmann I; Lindberg M; Sjöström CD; Langkilde AM; Heerspink HJL
    Nephrol Dial Transplant; 2020 Oct; 35(10):1700-1711. PubMed ID: 32862232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?
    Leehey DJ
    Kidney360; 2020 Apr; 1(4):292-299. PubMed ID: 35372914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease.
    Rikin S; Deccy S; Zhang C; Crandall J; Deng Y; Golestaneh L
    J Gen Intern Med; 2023 May; 38(7):1599-1605. PubMed ID: 36352203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The present and future treatment of pediatric type 2 diabetes.
    Van Name MA; Guandalini C; Steffen A; Patel A; Tamborlane W
    Expert Rev Endocrinol Metab; 2018 Jul; 13(4):207-212. PubMed ID: 30063424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.
    Bjornstad P; Cherney DZ; Maahs DM; Nadeau KJ
    Curr Diab Rep; 2016 Feb; 16(2):11. PubMed ID: 26803647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease.
    Yao L; Liang X; Wang P
    Am J Physiol Endocrinol Metab; 2023 Jun; 324(6):E531-E541. PubMed ID: 37166263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Therapies for Kidney Disease in People With Diabetes.
    Khurana N; James S; Coughlan MT; MacIsaac RJ; Ekinci EI
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e1-e24. PubMed ID: 34460928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years.
    Block TJ; Cooper ME
    Presse Med; 2023 Mar; 52(1):104178. PubMed ID: 37783423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
    Mazzieri A; Porcellati F; Timio F; Reboldi G
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria.
    Shah N; Perkovic V; Kotwal S
    Expert Rev Clin Pharmacol; 2022 Jul; 15(7):827-842. PubMed ID: 35912871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
    Karalliedde J; Winocour P; Chowdhury TA; De P; Frankel AH; Montero RM; Pokrajac A; Banerjee D; Dasgupta I; Fogarty D; Sharif A; Wahba M; Mark PB; Zac-Varghese S; Patel DC; Bain SC
    Diabet Med; 2022 Apr; 39(4):e14769. PubMed ID: 35080257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease.
    Górriz JL; Navarro-González JF; Ortiz A; Vergara A; Nuñez J; Jacobs-Cachá C; Martínez-Castelao A; Soler MJ
    Nephrol Dial Transplant; 2020 Jan; 35(Suppl 1):i13-i23. PubMed ID: 32003834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.